Diagnos Laboratorium Utama Tbk. vs Radana Bhaskara Finance Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Radana Bhaskara Finance Tbk. trades at Rp86 (market cap 575.74B, 258.6K 24h volume). The key difference: Radana Bhaskara Finance Tbk. is the larger of the two by market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (963.6K versus 258.6K). Which is the better fit depends on your goals.
| DGNS | HDFA | |
|---|---|---|
Market Cap | 310.75B | 575.74B |
Volume | 963.6K | 258.6K |
Lot | 9.64K | 2.59K |
Turnover | 217.67M | 22.27M |
Average Price | 225.89 | 86.12 |
Value | 217.67M | 22.27M |
Indicative Equilibrium Price | 226 | 86 |
Indicative Equilibrium Volume | 1K | 200 |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT HD Finance (the company) was incorporated under the name of PT Indonesia Lease Corporation base on notarial deed No.41 of Mr FA Tumbuan, S.H, dated 20 Sep, 1972. The Company's name has been changed from PT HD Finance Tbk to PT Radana Bhaskara Finance Tbk based on the Notarial Deed No. 136 dated May 21, 2014 of Jimmy Tanal, S.H., M.Kn.
Read more on HDFA →